Chemokines, particularly the CCR9/CCL25 and CXCL12/CXCR4 axes, play pivotal roles in lung cancer progression, immune cell recruitment, and tumor microenvironment remodeling. This evidence concerns the gene CCL25 and lung carcinoma.